Out of the top 10 most significantly differentially expressed genes in DBTRG cells, ADAM metallopeptidase with thrombospondin type 1 motif 14 (ADAMTS14) and vascular endothelial growth factor A (VEGFA) were both significantly associated with survival in patients with GBM (high expression, p < 0.05, Table 4). Here, ADAMTS14 is linked to glioblastoma.